The Justice Department’s Antitrust Division, together with its state co-Plaintiffs, filed a proposed settlement requiring broad divestitures to resolve Plaintiffs’ challenge to UnitedHealth Group’s (UNH) $3.3B acquisition of Amedisys (AMED). In addition, Amedisys would pay a $1.1M civil penalty to the United States for falsely certifying that it had provided “true, correct, and complete” responses under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, the DOJ announced. The proposed settlement would require UnitedHealth and Amedisys to divest 164 home health and hospice locations, including one affiliated palliative care facility, across 19 states, accounting for approximately $528M in annual revenue. “By number of facilities, the settlement would secure the largest divestiture of outpatient healthcare services to resolve a merger challenge,” the DOJ stated.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Mixed options sentiment in UnitedHealth with shares down 1.69%
- UnitedHealth’s (UNH) New CFO Wayne DeVeydt Cuts Ties with Rival Centene
- Moderately bullish activity in UnitedHealth with shares up 2.89%
- ‘Keep on Buying,’ Says Top Investor About UnitedHealth Stock
- Strategic Positioning and Prudent Management Drive UnitedHealth’s Buy Rating
